| 1.055 -0.105 (-9.05%) | 06-10 11:08 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 2.01  |
1-year : | 2.49 |
| Resists | First : | 1.72 |
Second : | 2.14 |
| Pivot price | 1.66 |
|||
| Supports | First : | 1.04 |
Second : | 0.87 |
| MAs | MA(5) : | 1.34 |
MA(20) : | 1.75 |
| MA(100) : | 1.81 |
MA(250) : | 3.95 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 26.8 |
D(3) : | 28.5  |
| RSI | RSI(14): 35.1 |
|||
| 52-week | High : | 18.22 | Low : | 1.04 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ STSS ] has closed below the lower bollinger band by 4.4%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ STSS ] is to continue within current trading range. It is unclear right now based on current values. 124.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 1.31 - 1.31 | 1.31 - 1.32 |
| Low: | 1.12 - 1.13 | 1.13 - 1.14 |
| Close: | 1.15 - 1.16 | 1.16 - 1.17 |
Sharps Technology Inc. is a medical device firm that manages the complete product lifecycle – from research and development to manufacturing, distribution, and sales – for its safety-engineered syringe products throughout the United States. A key offering is the Sharps Provensa, an ultra-low dead space syringe specifically designed for the efficient delivery of vaccines and other injectable pharmaceuticals. Established in 2017, the company maintains its headquarters in Melville, New York.
Tue, 02 Jun 2026
SkyAI rebrands and pivots to AI finance platform - The Globe and Mail
Thu, 28 May 2026
News On Sharps Technology Inc. (STSS) Now Under SKYA - Moomoo
Wed, 27 May 2026
Sharps Technology Becomes SkyAI, Inc. with New Ticker - GlobeNewswire
Fri, 15 May 2026
Sharps Technology Reports Continued Growth in Q1 2026 Highlighting Strengthened Balance Sheet and Strong Treasury Execution - PR Newswire
Fri, 15 May 2026
Saba entities report 6.95% stake in Sharps Technology (STSS) amendment - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 42 (M) |
| Shares Float | 34 (M) |
| Held by Insiders | 8.4 (%) |
| Held by Institutions | 24.3 (%) |
| Shares Short | 588 (K) |
| Shares Short P.Month | 626 (K) |
| EPS | -64.49 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 4.53 |
| Profit Margin | 0 % |
| Operating Margin | -137.3 % |
| Return on Assets (ttm) | -10.4 % |
| Return on Equity (ttm) | -380.3 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0.06 |
| Sales Per Share | 0.08 |
| EBITDA (p.s.) | -0.39 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -17 (M) |
| Levered Free Cash Flow | 89 (M) |
| PE Ratio | -0.02 |
| PEG Ratio | 0 |
| Price to Book value | 0.23 |
| Price to Sales | 12.58 |
| Price to Cash Flow | -2.65 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|